Updated results from the phase 2 CENTAURUS study of daratumumab (DARA) monotherapy in patients with intermediate-risk or high-risk smoldering multiple myeloma (SMM) Meeting Abstract


Authors: Landgren, O.; Cavo, M.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P. M.; Estell, J.; Sandhu, I.; Jenner, M.; Williams, C.; van de Donk, N. W. C. J.; Beksac, M.; Goldschmidt, H.; Moreau, P.; Kuppens, S.; Bandekar, R.; Neff, T.; Cortoos, A.; Clemens, P. L.; Qi, M.; Adams, H. 3rd; Hofmeister, C. C.
Abstract Title: Updated results from the phase 2 CENTAURUS study of daratumumab (DARA) monotherapy in patients with intermediate-risk or high-risk smoldering multiple myeloma (SMM)
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454837605318
PROVIDER: wos
Notes: Meeting Abstract: 1994 -- Source: Wos
MSK Authors
  1. Carl Ola Landgren
    198 Landgren
Related MSK Work